Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeff A Kingsley

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers in Cardiovascular Medicine|July 24, 2025
Association between obesity and cardiac conduction defectsMohamed A Mostafa, Jeff A Kingsley, Elsayed Z Soliman, et al.
Progress in Cardiovascular Diseases|May 2, 2026
Lipoprotein(a), remnant cholesterol, and high-sensitivity C-reactive protein as complementary biomarkers for myocardial infarction risk assessmentRichard Kazibwe, Christopher L Schaich, Jeff A Kingsley, et al.
European Journal of Preventive Cardiology|April 16, 2026
Lipoprotein(a), High-Sensitivity C-Reactive Protein, and Incident ASCVD Risk in Individuals Without Standard Modifiable Risk FactorsRichard Kazibwe, Christopher L Schaich, Jeff A Kingsley, et al.
Journal of the American Heart Association|February 11, 2026
Lipoprotein(a), Insulin Resistance, and Cardiovascular Disease in the UK BiobankRichard Kazibwe, Christopher L Schaich, Parag A Chevli, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers in Cardiovascular Medicine|July 24, 2025
Association between obesity and cardiac conduction defectsMohamed A Mostafa, Jeff A Kingsley, Elsayed Z Soliman, et al.
Progress in Cardiovascular Diseases|May 2, 2026
Lipoprotein(a), remnant cholesterol, and high-sensitivity C-reactive protein as complementary biomarkers for myocardial infarction risk assessmentRichard Kazibwe, Christopher L Schaich, Jeff A Kingsley, et al.
European Journal of Preventive Cardiology|April 16, 2026
Lipoprotein(a), High-Sensitivity C-Reactive Protein, and Incident ASCVD Risk in Individuals Without Standard Modifiable Risk FactorsRichard Kazibwe, Christopher L Schaich, Jeff A Kingsley, et al.
Journal of the American Heart Association|February 11, 2026
Lipoprotein(a), Insulin Resistance, and Cardiovascular Disease in the UK BiobankRichard Kazibwe, Christopher L Schaich, Parag A Chevli, et al.
Pageof 1